Summary of live webinar presented in October, 2018 by Stealth BioTherapeutics (Stealth BT).

The following is a summary of a live webinar presented by Reenie McCarthy, CEO and Jim Carr, PharmD, Chief Clinical Development Officer of Stealth BioTherapeutics (Stealth BT). All investigational product candidates mentioned in this summary are investigational new drugs. They are not approved by the FDA for the treatment of any disease, condition or ailment. As always, please consult with your doctor when considering treatment options or clinical trials available to you or your loved one. See the summary herewww.mitotrials.com   www.clinicaltrials.gov

2018-11-29T09:07:43+00:00
%d bloggers like this: